Immunotherapy in Germany - Innovative Approach in Cancer Treatment

13/03/2026

Good news from USA!

A year ago we shared the story of Dallas Carroll, a young mother from Florida who was diagnosed with stage IV breast cancer with metastases to the bones and liver. Dallas decided to pursue a personalized treatment approach that included a dendritic cell vaccine, a form of immunotherapy that uses the patient’s own immune system to fight cancer.

Over the following months, doctors observed a strong response to treatment. The metastases in her liver and bones disappeared, and the remaining tumor in the breast was removed during a bilateral mastectomy.

Today Dallas remains with no evidence of active cancer. She continues regular follow-up scans and supportive immunotherapy.

Her case highlights the potential of modern personalized immunotherapy approaches in cancer treatment.

The link to the full YouTube video is provided below.

The dendritic cell vaccine therapy is a cross between a vaccine and cell therapy. Anchor Lauren St. Germain stayed in touch with Dallas Carroll while she rec...

07/02/2026

We encourage you to read the story of Pamela Goldberger, who overcame glioblastoma by adding dendritic cell therapy into her treatment.
The article and accompanying video available at the link below were published by the Fox News.

The article tells the story of a 65-year-old woman from the United States who was diagnosed in 2023 with glioblastoma multiforme—one of the most aggressive and deadly forms of brain cancer. Standard treatment for this type of tumor, which includes surgery, radiotherapy, and chemotherapy, is usually associated with a very poor prognosis, with an average survival time of approximately 14–16 months.

After undergoing surgery and standard oncological treatment, the patient decided to participate in a clinical trial of an experimental immunotherapy based on dendritic cells. This therapy involves the use of the patient’s own immune system cells. Dendritic cells are collected from the patient’s blood and then, in a laboratory setting, “trained” to recognize tumor antigens obtained from the removed tumor tissue. Once prepared, they are administered back to the patient in the form of a vaccine.

The goal of this therapy is to activate the immune system so that the body can independently recognize and destroy remaining cancer cells that could not be surgically removed or eliminated through standard treatment.

According to the account presented in the article, the patient experienced an exceptionally positive response to the therapy. More than two and a half years have passed since the diagnosis, and the disease remains under control. The woman has returned to an active, everyday life—spending time with her grandchildren, playing tennis, feeling well, maintaining physical fitness, and functioning normally in her family and social life.

The authors emphasize that dendritic cell therapy is still considered experimental and is mainly available through clinical trials or private clinics. Nevertheless, this case demonstrates that cell-based immunotherapy may represent an important complement to the treatment of aggressive cancers, particularly in situations where standard therapies have very limited effectiveness.

A clinical trial of an experimental cell therapy shows promising results for glioblastoma patients, with tumors disappearing on MRIs after the breakthrough cancer treatment.

03/06/2025

"While glioblastoma is not considered a curable condition, Ms Ackroyd said her husband has shown an "absolutely remarkable" improvement and the tumour has reduced."

"Now we're sort of living some sort of normal-ish life again. We can socialise with friends and go and see our daughter in a school play."

"If we relied on the NHS, my husband would not be here now."

===============

The BBC recently reported on the case of Steve Ackroyd from North London, who was diagnosed with glioblastoma in 2022. The link to the original text below.

Steve Ackroyd is undergoing private treatment abroad for his inoperable brain cancer.

25/01/2025

We encourage you to read the story of Dallas Carroll, a young mother who was diagnosed at the age of 29 with stage 4 breast cancer with metastases to her bones and liver. Dallas was told that with standard treatment, her prognosis would be between 5 and 7 years. However, she chose a personalized treatment supplemented with a dendritic cell vaccine.

After six doses, Dallas’s breast tumor shrank from 80 millimeters to 11 millimeters. Some of the bone metastases showed signs of healing, and the liver lesions also decreased in size. Since she responded so well, Dallas began a second round of eight vaccinations in May 2024.

Scans after the second round of vaccines showed further disease reduction and the complete disappearance of a metastasis in her spine. At the end of June, she began chemotherapy, hoping that her previous immune response would make the treatment more effective.

The dendritic cell vaccine, as part of IMI (Individual Multimodal Immunotherapy), is available at the IOZK Clinic in Cologne, Germany.

Link to the full article below.

02/02/2024

Recently, an article titled "Fought Path to Life - Immunotherapy as a Ray of Hope" was published on the German website gesunder-koerper.info, in which 25-year-old Jasper Maes, diagnosed with glioblastoma multiforme, shares how comprehensive immunotherapy at a clinic in Cologne helps him fight the most malignant opponent.

Below is the English translation of the article and the link to the original publication in German:

"Fought Path to Life - Immunotherapy as a Ray of Hope

At the age of 25, Jasper Maes was diagnosed with glioblastoma - a malignant brain tumor. In an interview, the young man tells why he decided on immunotherapy in Germany and how he feels now.

Were there any symptoms that indicated you might have cancer?

I was lucky or unlucky not to experience any symptoms - until my body went into "shutdown mode." The pressure in my head caused not only headaches but also nausea, vomiting reflexes, and vomiting. That's why I was transported to the intensive care unit, where a malignant brain tumor was diagnosed. A few days later, I underwent urgent tumor removal surgery. The terrible news that it was glioblastoma multiforme came after the biopsy.

What was your reaction to such a difficult diagnosis?

I was completely stunned and could barely believe it. I immediately asked myself what I had done wrong in life to get sick that badly. After all, I was always active and took care of my health: I don't smoke ci******es, and I only drank alcohol occasionally. After the diagnosis, I immediately stopped doing it. I wanted to find a way to cure.

Did you search for various treatment options on the Internet yourself or did you consult with a doctor?

I tried to search the internet for stories of people who survived a disease similar to mine. I was looking for positive relations. However, I usually stopped after a few Google searches because the information I found about glioblastoma was more depressing than motivating. In addition to conventional treatment with radiotherapy and chemotherapy, I first sought a second opinion at another hospital.

You live in Belgium and decided on immunotherapy in Germany. Why?

Through a friend of my father, we were contacted with a researcher at the University of Antwerp who recommended a cancer specialist in Germany. The doctor gave me some hope by talking about his successful attempts with immunotherapy. Although there was no guarantee of success, I felt that I should try and I had nothing to lose.

Can you describe the immunotherapy you decided on?

With conviction in the decisive role of my own immune system in the fight against the tumor, I not only actively worked on strengthening it but also tried immunotherapy. It includes modulated electrohyperthermia therapy combined with administration of the Newcastle disease virus. This involves weakening cancer cells by heating them using EHT technology, allowing the oncolytic virus to attack and destroy them.

I started this therapy in parallel with conventional chemotherapy. In the second part of the treatment, a dendritic cell vaccine is produced from my extracted blood to stimulate my own immune system to fight cancer cells.

How do you feel today?

Given my situation and the disease I had to fight and still fight, I couldn't be better. I am very happy that I started immunotherapy because I really feel that it has made a big difference in my fight against cancer. I firmly believe that an active and healthy lifestyle increases the chances in the fight against this terrible disease. However, I still have a great fear of relapse and live very cautiously. But I am extremely lucky and happy to be where I am today. I try more and more to return to "normal" life."

Interested individuals are encouraged to ask questions about therapy here.
Email: [email protected]
Tel./Whatsapp: +44 7547 901 434

Im Alter von 25 Jahren wurde bei Jasper Maes die Diagnose Glioblastom, ein bösartiger Hirntumor, gestellt. Im Interview teilt der junge Mann mit, warum er sich für eine Immuntherapie in Deutschland entschieden hat und wie es ihm heute geht. Gab es Anzeichen, dass Sie Krebs haben könnten? Ich hatt...

19/01/2024

Short update for those interested in the interview with Prof. Van Gool.
Our recently released material had a technical issue - the sound was recorded in mono, so it was only audible in one earphone/speaker.
Today, we have uploaded the new, corrected version in stereo (see link below).
We encourage you to check out the content where I asked the main oncologist at the IOZK clinic the most frequently stated questions by You.

Especially for you, I interviewed the chief oncologist at the IOZK clinic in Cologne, where I asked the most frequently asked questions.(Stereo Version)Below...

12/01/2024

Find Us On YouTube!
On our channel we have just released previously announced interview with the main oncologist of the IOZK clinic in Cologne.
All your most frequently asked questions were answered.
The timestamps list is attached with the video for easier navigation between questions.
Below you can find the link to the FB post that includes the video.
In case of any further questions please contact us directly. 📸 Look at this post on Facebook https://www.facebook.com/share/AgJNuM7CizCCNzYH/?mibextid=WC7FNe

30/12/2023

Below you will find the previously announced interview with the chief oncologist of the IOZK clinic in Cologne, in which I asked the most frequently stated questions by you. I am also attaching a list of these questions with timestamps for easier navigation. Feel free to familiarize yourself with the material. If you have any further questions, I am available.
Bart Kinas
Email: [email protected]
Tel/Whatsapp: +44 7547 901 434

0:00 – Introduction
0:58 – What method of cancer treatment is offered at the clinic and what does it involve?
4:29 – What is dendritic cell vaccination, and how does it work?
7:45 – More about the Nobel laureate for the discovery of dendritic cells, R. Steinman
11:41 – Is the IOZK clinic the only place in Europe where dendritic cell vaccination is available?
14:26 – Are there scientific studies confirming the effectiveness of this therapy?
18:20 – Is the therapy effective, and does the clinic have its own statistics?
21:49 – Can the therapy be used for all types of cancer?
24:24 – Can this treatment be combined with radiotherapy and chemotherapy? Do the clinic's doctors collaborate with physicians in Poland? 27:18 – Is the therapy safe? What side effects does it cause?
28:49 – What is the treatment schedule, and how long does the therapy last?
31:24 – How much does the therapy cost?
35:01 – Ending